Valuation: JBCHEMICAPAR

Market Cap 387B 4.05B 3.48B 3.25B 2.98B 5.6B 5.69B 38.3B 15B 194B 15.21B 14.88B 642B P/E 2027 *
43.3x
P/E 2028 * 33x
Enterprise Value 387B 4.05B 3.48B 3.25B 2.98B 5.6B 5.69B 38.3B 15B 194B 15.21B 14.88B 642B EV / Sales 2027 *
8.14x
EV / Sales 2028 * 7.12x
Free-Float
-
Yield 2027 *
0.72%
Yield 2028 * 0.86%
1 day-3.73%
3 months+10.95%
6 months+21.26%
Current year+32.51%
Current year 1,777.05
Extreme 1777.05
2,509.4
1 year 1,603.05
Extreme 1603.05
2,509.4
3 years 1,246.05
Extreme 1246.05
2,509.4
5 years 669.52
Extreme 669.525
2,509.4
10 years 118
Extreme 118
2,509.4
Date Insider Type Main position Quantity % Market Cap.
22/09/25 Sell

Chief Executive Officer

24,785 0.0159%
22/09/25 Sell

Chief Executive Officer

19,312 0.0124%
15/09/25 Sell

Chief Executive Officer

965 0.0006%

Financials

2027 *2028 *
Net sales 47.6B 498M 427M 399M 366M 688M 700M 4.71B 1.84B 23.88B 1.87B 1.83B 78.94B 54.41B 569M 488M 456M 418M 787M 800M 5.38B 2.11B 27.29B 2.14B 2.09B 90.22B
Net income 9B 94.13M 80.75M 75.4M 69.18M 130M 132M 890M 348M 4.51B 353M 346M 14.92B 11.85B 124M 106M 99.34M 91.14M 171M 174M 1.17B 459M 5.95B 466M 456M 19.66B
Net Debt - -
Logo JBCHEMICAPAR
J.B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company specializes in gastroenterology, hypertension and dermatology. It is also focused on other therapeutic categories like nephrology, respiratory, virology, diabetes, and nicotine replacement therapy (NRT). The Company is engaged in the business of manufacturing and marketing of a diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its brands include Nicardia, Cilacar, Rantac, Metrogyl, and Cilacar-T. It specializes in manufacturing medicated and herbal lozenges. It produces hard-candy lozenges, soft-center lozenges and powder-filled lozenges for varied medical needs. Its API products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Nifedipine, and others. It maintains a direct presence in Russia and South Africa, while leveraging distributor partnerships across the United States, Asia, Africa, and Latin America.
Employees
5,602
Sector
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2,412.25INR
Average target price
2,328.14INR
Spread / Average Target
-3.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. JBCHEPHARM Stock